Cardiovascular Diseases in India: Current Epidemiology and Future Directions
- PMID: 27142605
- DOI: 10.1161/CIRCULATIONAHA.114.008729
Cardiovascular Diseases in India: Current Epidemiology and Future Directions
Abstract
Cardiovascular diseases (CVDs) have now become the leading cause of mortality in India. A quarter of all mortality is attributable to CVD. Ischemic heart disease and stroke are the predominant causes and are responsible for >80% of CVD deaths. The Global Burden of Disease study estimate of age-standardized CVD death rate of 272 per 100 000 population in India is higher than the global average of 235 per 100 000 population. Some aspects of the CVD epidemic in India are particular causes of concern, including its accelerated buildup, the early age of disease onset in the population, and the high case fatality rate. In India, the epidemiological transition from predominantly infectious disease conditions to noncommunicable diseases has occurred over a rather brief period of time. Premature mortality in terms of years of life lost because of CVD in India increased by 59%, from 23.2 million (1990) to 37 million (2010). Despite wide heterogeneity in the prevalence of cardiovascular risk factors across different regions, CVD has emerged as the leading cause of death in all parts of India, including poorer states and rural areas. The progression of the epidemic is characterized by the reversal of socioeconomic gradients; tobacco use and low fruit and vegetable intake have become more prevalent among those from lower socioeconomic backgrounds. In addition, individuals from lower socioeconomic backgrounds frequently do not receive optimal therapy, leading to poorer outcomes. Countering the epidemic requires the development of strategies such as the formulation and effective implementation of evidence-based policy, reinforcement of health systems, and emphasis on prevention, early detection, and treatment with the use of both conventional and innovative techniques. Several ongoing community-based studies are testing these strategies.
Keywords: India; cardiovascular diseases; coronary disease; epidemiology; prevention & control; risk.
© 2016 American Heart Association, Inc.
Similar articles
-
Regional case studies--India.Nestle Nutr Workshop Ser Pediatr Program. 2009;63:15-24; discussion 41-6, 259-68. doi: 10.1159/000209969. Nestle Nutr Workshop Ser Pediatr Program. 2009. PMID: 19346764
-
Reducing the Global Burden of Cardiovascular Disease, Part 1: The Epidemiology and Risk Factors.Circ Res. 2017 Sep 1;121(6):677-694. doi: 10.1161/CIRCRESAHA.117.308903. Circ Res. 2017. PMID: 28860318 Review.
-
The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation.Circulation. 2016 Jun 7;133(23):e674-90. doi: 10.1161/CIR.0000000000000395. Epub 2016 May 9. Circulation. 2016. PMID: 27162236
-
Women's cardiovascular health in India.Heart. 2012 Mar;98(6):456-9. doi: 10.1136/heartjnl-2011-300957. Epub 2012 Jan 3. Heart. 2012. PMID: 22217546
-
Recent trends in coronary heart disease epidemiology in India.Indian Heart J. 2008 Mar-Apr;60(2 Suppl B):B4-18. Indian Heart J. 2008. PMID: 19359764 Review.
Cited by
-
Hypothyroidism in acute coronary syndrome - A prospective Indian study.Indian Heart J. 2024 Jan-Feb;76(1):44-47. doi: 10.1016/j.ihj.2023.12.008. Epub 2024 Jan 29. Indian Heart J. 2024. PMID: 38296053 Free PMC article.
-
Compliance to secondary prevention strategies for coronary artery disease: a hospital-based cross-sectional survey from Ernakulam, South India.BMJ Open. 2020 Oct 10;10(10):e037618. doi: 10.1136/bmjopen-2020-037618. BMJ Open. 2020. PMID: 33039999 Free PMC article.
-
Pharmacovigilance in India: Present Scenario and Future Challenges.Drug Saf. 2019 Mar;42(3):339-346. doi: 10.1007/s40264-018-0730-7. Drug Saf. 2019. PMID: 30269244
-
Therapeutic Usefulness of a Novel Calcium Channel Blocker Azelnidipine in the Treatment of Hypertension: A Narrative Review.Cardiol Ther. 2022 Dec;11(4):473-489. doi: 10.1007/s40119-022-00276-4. Epub 2022 Aug 13. Cardiol Ther. 2022. PMID: 35969319 Free PMC article. Review.
-
Lipoprotein(a): An underrecognized genetic risk factor for malignant coronary artery disease in young Indians.Indian Heart J. 2019 May-Jun;71(3):184-198. doi: 10.1016/j.ihj.2019.04.007. Epub 2019 May 2. Indian Heart J. 2019. PMID: 31543191 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical